Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SGS Acquires aster.cephac | Contract Pharma
Breaking News

SGS Acquires aster.cephac

SGS has acquired aster.cephac, a full service provider of early clinical pharmacology trials and bioanalytical drug development services headquartered in Paris, France. With its 82-bed, newly refurbished state-of-the-art clinic, aster.cephac is one of the largest intensive care facilities in the world with access to a large volunteer base in Europe. Also, the company has recently invested in a modern and GMP-conforming pharmacy. Its facilities are in full compliance with the recent EU Directive.

SGS Life Science Services now offers three clinical research units (two in Belgium, one in France) with a capacity of 172 beds and conducts more than 100 Phase I trials a year. Aster.cephac’s bioanalytical research center located in Poitiers is a large independent bioanalytical unit in Europe and a leader in mass spectrometry (LC-MS/MS) services and immunoanalysis.

With this acquisition, SGS now offers a capacity of four labs (France, Belgium, Thailand, India) with a technical platform of 28 recent generation LC-MS/MS machines and a portfolio of about 700 methods. The acquisition is part of SGS’s strategic growth plan establishing a presence for clinical research services in one of Europe’s leading pharmaceutical markets.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters